Immunology and Microbiology
Liquid
100%
Rituximab
100%
Artery
100%
Peritoneal Dialysis
100%
Galectin 3
100%
Urinary Excretion
100%
Antimicrobial Agent
40%
Antimicrobial Activity
40%
Glucocorticoid
28%
Disk Diffusion
20%
High Performance Liquid Chromatography
20%
Escherichia coli
20%
Peritonitis
20%
Pseudomonas aeruginosa
20%
Limb
16%
Membranous Glomerulonephritis
14%
ANCA Associated Vasculitis
14%
Hypogammaglobulinemia
14%
Kidney Function
14%
Ankle
10%
Glomerulus Filtration
10%
Vasculitis
8%
Creatinine Urine Level
8%
Long Term Survival
8%
Pharmacology, Toxicology and Pharmaceutical Science
Aztreonam
100%
Pharmacokinetics
100%
Meropenem
100%
Rituximab
100%
Urokinase Receptor
100%
Disease Severity
100%
Minimum Inhibitory Concentration
71%
Dialysis Fluid
57%
Infectious Agent
28%
Kidney Disease
20%
Pharmacodynamics
14%
Pharmacokinetic Modeling
14%
Peritonitis
14%
Creatinine
10%
Sclerosis
10%
Gastrointestinal Infection
7%
Membranous Glomerulonephritis
7%
Infectious Complication
7%
Glomerulopathy
7%
Immunoglobulin Deficiency
7%
Respiratory Tract Infection
7%
ANCA Associated Vasculitis
7%
Medicine and Dentistry
Nephropathy
100%
Infection
100%
Rituximab
100%
Urokinase Receptor
100%
Body Mass Index
23%
Glucocorticoid
15%
Creatinine
7%
Kidney Function
7%
Respiratory Tract Infection
7%
Retrospective Cohort Study
7%
Membranous Glomerulonephritis
7%
Glomerulopathy
7%
ANCA Associated Vasculitis
7%
Gastrointestinal Infection
7%
Urinary Tract
7%
Infectious Complication
7%
Hypogammaglobulinemia
7%
Adverse Event
7%
Immunity
7%
